Jesús María
Prieto Valtueña
Chercheur jusqu' 2014
French Institute of Health and Medical Research
París, FranciaPublications en collaboration avec des chercheurs de French Institute of Health and Medical Research (11)
2018
-
MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Hepatology, Vol. 67, Núm. 4, pp. 1420-1440
2013
2012
-
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
Vaccine, Vol. 30, Núm. 18, pp. 2848-2858
-
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651
2011
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31
2010
-
Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis
Vaccine, Vol. 28, Núm. 44, pp. 7146-7154
2009
-
The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection
Journal of Virology, Vol. 83, Núm. 16, pp. 8012-8020
2008
-
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis
Hepatology, Vol. 48, Núm. 4, pp. 1251-1261
2007
-
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo
Journal of Immunology, Vol. 178, Núm. 2, pp. 748-756
2000
-
Transduction efficacy, antitumoral effect, and toxicity of adenovirus- mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model
Cancer Gene Therapy, Vol. 7, Núm. 5, pp. 657-662
1994
-
Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study
CardioVascular and Interventional Radiology, Vol. 17, Núm. 1, pp. 7-11